July 7, 2026

Emmecell Announces RMAT Designation for EO2002 for Corneal Endothelial Disease

​

June 16, 2026

Emmecell Announces Closing of Strategic Financing

​

January 16, 2026

Emmecell Appoints Ramin Valian as Chief Executive Officer

​